Blog
Advisory: Chevron to Present at Goldman Sachs Energy, CleanTech & Utilities Conference 2025
Mike Wirth, Chairman and CEO of Chevron Corporation (NYSE: CVX), will take part in the Goldman Sachs Energy, CleanTech & Utilities Conference 2025 on Wednesday, January 8, 2025, at 9:00 AM ET
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 2, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
ArcBest Announces Its Fourth Quarter 2024 Earnings Conference Call
ArcBest® (Nasdaq: ARCB) will announce its fourth quarter 2024 financial results before the market opens on Friday, January 31, 2025. A conference call with company executives will be held that day
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 58,650
Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine
SiteOne Landscape Supply’s Devil Mountain Joint Venture Acquires Pacific Nurseries
SiteOne® Landscape Supply, Inc. (NYSE: SITE) announced today that its majority-owned joint venture, Devil Mountain Wholesale Nursery, has acquired Pacific Nurseries, a wholesale distributor of
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Novocure (NASDAQ: NVCR) announced today that management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025. Ashley Cordova, Chief Executive
RPM Declares Quarterly Dividend
RPM International Inc. (NYSE: RPM) today announced that its board of directors declared a regular quarterly cash dividend of $0.51 per share, payable on January 31, 2025, to stockholders of record
Trane Technologies Completes Acquisition of BrainBox AI
Trane Technologies (NYSE: TT), a global climate innovator, announced that it has completed the acquisition of BrainBox AI, a pioneer in autonomous HVAC controls and generative Artificial
Streamlining Elliptic Labs Smartphone Launch Updates
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, is introducing a new communication
Pursuit Completes Acquisition of the Jasper SkyTram in Jasper National Park
Pursuit Attractions and Hospitality Inc. (“Pursuit”) (NYSE: PRSU), announced today that it closed on the previously announced acquisition of the Jasper SkyTram, which is located in Canada’s iconic
Douglas Emmett Announces Dates for Its 2024 Fourth Quarter Earnings Results and Live Conference Call
Douglas Emmett, Inc. (NYSE:DEI), a real estate investment trust (REIT), announced today that it plans to release its 2024 fourth quarter earnings results after market close on Tuesday, February 4
UDR, Inc. Announces Executive Management Promotions and Leadership Transition Plans
UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust, today announced the following Executive Management promotions and Leadership Transition plans effective
Cohu to Participate at 27th Annual Needham Growth Conference
Cohu, Inc. (NASDAQ: COHU), a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, today announced that management will participate virtually at
VICI Properties Inc. Announces Release Date for Fourth Quarter and Full Year 2024 Results
VICI Properties Inc. (NYSE: VICI) (“VICI Properties” or the “Company”) announced today that it will release its fourth quarter and full year 2024 financial results on Thursday, February 20, 2025
TechnipFMC to Speak at Goldman Sachs Energy, CleanTech & Utilities Conference
TechnipFMC (NYSE: FTI) announced today that Doug Pferdehirt, Chair and Chief Executive Officer, will speak at the Goldman Sachs Energy, CleanTech & Utilities Conference on Tuesday, January 7, 2025
Verisign to Report Fourth Quarter and Full Year 2024 Financial Results
VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today announced that its earnings call for the fourth quarter and full year
Resources Connection Reports Financial Results for Second Quarter Fiscal 2025
Resources Connection, Inc. (Nasdaq: RGP) (the “Company”), a professional services firm, today announced its financial results for its second quarter of fiscal 2025 ended November 23, 2024.
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2024, includes Reg.-NMS Execution Statistics
Interactive Brokers Group, Inc. (Nasdaq: IBKR) an automated global electronic broker, today reported its Electronic Brokerage monthly performance metrics for December.
Brokerage highlights for
Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 30
Marsh McLennan (NYSE: MMC), a global leader in risk, strategy and people, will announce fourth quarter financial results via news release on Thursday, January 30, 2025, before the market opens. The
Ladder Announces $850 Million Revolving Credit Facility to Upsize and Extend Existing Facility and Reduce Cost of Debt
Ladder Capital Corp (“Ladder,” the “Company,” “we” or “our”) (NYSE: LADR), a leading diversified commercial real estate finance platform, recently closed and subsequently upsized a revolving credit
Hexcel Schedules Fourth Quarter 2024 Earnings Release and Conference Call
Hexcel Corporation (NYSE: HXL) announced today that it will report financial results for its fourth quarter of 2024 on Wednesday, January 22 after the market close.
The company will host a
Scholar Rock to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious



